Trials / Completed
CompletedNCT02008097
Clinical Benefits of B-Flow Ultrasound
Evaluation of Clinical Benefits of B-Flow With the LOGIQ E9 Ultrasound System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (actual)
- Sponsor
- University of Washington · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The goals of this study are to evaluate the efficacy of the B-flow capability on the LOGIQ E9 system in three clinical focus areas. 1. Liver transplant patients: Improved real-time visualization of liver vessels is needed to improve diagnosis and assessment following stenting or angioplasty. 2. Renal artery disease: Improved real-time visualization of the renal arteries would enable a more rapid and accurate assessment of renal artery disease (stenosis, dissection, occlusion, aneurysm) and facilitate follow-up evaluations after renal artery interventions. 3. Pregnancy: We are proposing to use B-flow ultrasound as a way to evaluate placenta perfusion and assay for potential ischemia.
Conditions
- Evidence of Liver Transplantation
- Arterial Occlusive Diseases
- Hypertension
- Pregnancy, High Risk
- Pregnancy
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GE LOGIQ E9 Ultrasound System | Subjects will have an ultrasound exam using the GE LOGIQ E9 Ultrasound System which has computer software that combines the color-flow image and B-mode image to produce the new "B-Flow" method of ultrasound. |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2015-08-31
- Completion
- 2015-09-01
- First posted
- 2013-12-11
- Last updated
- 2018-05-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02008097. Inclusion in this directory is not an endorsement.